[3H]MRS 1754, a selective antagonist radioligand for A2B adenosine receptors

被引:81
|
作者
Ji, XD
Kim, YC
Ahern, DG
Linden, J
Jacobson, KA
机构
[1] NIDDKD, Mol Recognit Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA
[2] NEN Life Sci Prod, Boston, MA 02118 USA
[3] Univ Virginia, Hlth Sci Ctr, Dept Internal Med & Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA
关键词
G protein-coupled receptors; tritium purines; xanthines; adenosine analogues;
D O I
10.1016/S0006-2952(01)00531-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
MRS 1754 [N-(4-cyanophenyl)-2-[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)-phenoxy]acetamide] is a selective antagonist ligand of A(2B) adenosine receptors. This is the least well-defined adenosine receptor subtype, and A(2B) antagonists have potential as antiasthmatic drugs. For use as a radioligand, MRS 1754, a p-cyanoanilide xanthine derivative, was tritiated on the propyl groups in a two-step reaction using a p-carboxamido precursor, which was dehydrated to the cyano species using trifluoroacetic anhydride. [H-3]MRS 1754 (150 Ci/mmol) bound to recombinant human A(2B) adenosine receptors in membranes of stably transfected HEK-293 cells. Specific binding was saturable, competitive, and followed a one-site model, with a K-D value of 1.13 +/- 0.12 nM and a B-max value of 10.9 +/- 0.6 pmol/mg protein. Specific binding utilizing 0.7 nM [H-3]MRS 1754 was > 70% of total binding. The affinity calculated from association and dissociation binding constants was 1.22 nM (N = 4). Binding to membranes expressing rat and human A(1) and A(3), adenosine receptors was not significant, and binding in membranes of HEK-293 cells expressing human A(2A) receptors was of low affinity (K-D > 50 nM). The effects of cations and chelators were explored. Specific binding was constant over a pH range of 4.5 to 6.5, with reduced binding at higher pH. The pharmacological profile in competition experiments with [H-3]MRS 1754 was consistent with the structure-activity relationship for agonists and antagonists at A(2B) receptors. The K-i values of XAC (xanthine amine congener) and CPX (8-cyclopentyl-1,3-diproplylxanthine) were 16 and 55 nM, respectively. NECA (5'-N-ethylcarboxamidoadenosine) competed for [H-3]MRS 1754 binding with a K-i of 570 nM, similar to its potency in functional assays. Thus, [H-3]MRS 1754 is suitable as a selective, high-affinity radioligand for A(2B) receptors. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:657 / 663
页数:7
相关论文
共 50 条
  • [21] Characterisation of the binding of the antagonist radioligand [3H]-ZM241385 to A2A adenosine receptors in particulate and slice preparations from porcine striatum
    Alexander, SPH
    Hamilton, EL
    Pollock, AC
    Tarrant, RJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 : U96 - U96
  • [22] [3H]MRE 3008F20:: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors
    Varani, K
    Merighi, S
    Gessi, S
    Klotz, KN
    Leung, E
    Baraldi, PG
    Cacciari, B
    Romagnoli, R
    Spalluto, G
    Borea, PA
    MOLECULAR PHARMACOLOGY, 2000, 57 (05) : 968 - 975
  • [23] EFFECT OF ADENOSINE 2B RECEPTOR ANTAGONIST MRS1754 ON FIBROSIS PROGRESSION AND REGRESSION IN MICE
    Resa, T. C.
    Kim, Y. O.
    Stoll, M.
    Robson, S.
    Schuppan, D.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S461 - S461
  • [24] Synthesis and preliminary evaluation of [3H]PSB-0413, a selective antagonist radioligand for platelet P2Y12 receptors
    El-Tayeb, A
    Griessmeier, KJ
    Müller, CE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (24) : 5450 - 5452
  • [25] Antagonist pharmacology of adenosine A2B receptors from rat, guinea pig and dog
    Fozard, JR
    Baur, F
    Wolber, C
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 : U65 - U65
  • [26] Antagonist pharmacology of adenosine A2B receptors from rat, guinea pig and dog
    Fozard, JR
    Baur, F
    Wolber, C
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 475 (1-3) : 79 - 84
  • [27] Adenosine A2B receptors in cancer cells
    Klotz, Karl-Norbert
    PURINERGIC SIGNALLING, 2010, 6 (01) : 66 - 67
  • [28] Adenosine A2B receptors as therapeutic targets
    Feoktistov, I
    Wells, JN
    Biaggioni, I
    DRUG DEVELOPMENT RESEARCH, 1998, 45 (3-4) : 198 - 206
  • [29] A2B adenosine receptors in immunity and inflammation
    Hasko, Gyoergy
    Csoka, Balazs
    Nemeth, Zoltan H.
    Vizi, E. Sylvester
    Pacher, Pal
    TRENDS IN IMMUNOLOGY, 2009, 30 (06) : 263 - 270
  • [30] TREATMENT WITH THE SELECTIVE ADENOSINE 2B RECEPTOR ANTAGONIST MRS1754 RESULTS IN ALLEVIATED HEPATIC COLLAGEN DEPOSITION DURING FIBROSIS PROGRESSION
    Stoll, M.
    Kim, Y. O.
    Hebig, B.
    Schuppan, D.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S160 - S160